Viewing Study NCT00003557

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 6:50 PM
Ignite Modification Date: 2025-12-30 @ 7:52 AM
Study NCT ID: NCT00003557
Status: COMPLETED
Last Update Posted: 2014-03-06
First Post: 1999-11-01
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Dolastatin 10 in Treating Patients With Metastatic Or Recurrent Liver, Bile Duct, or Gallbladder Cancer
Sponsor: University of Chicago
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Extrahepatic Bile Duct Cancer View
None Gallbladder Cancer View
None Liver Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None advanced adult primary liver cancer View
None recurrent adult primary liver cancer View
None unresectable gallbladder cancer View
None recurrent gallbladder cancer View
None unresectable extrahepatic bile duct cancer View
None recurrent extrahepatic bile duct cancer View
None adult primary hepatocellular carcinoma View
None cholangiocarcinoma of the gallbladder View